TAMIKA ROSSER: Open Payments
NPI 1689015257 · HIRAM, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$256 in 12 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $130 · 2025 $256
Food & beverage: $256
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $90 |
| SANOFI-AVENTIS U.S. LLC | 2 | $46 |
| Dynavax Technologies Corporation | 1 | $23 |
| Saluda Medical Americas, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Lilly USA, LLC | 1 | $15 |
| ABBVIE INC. | 1 | $15 |
Products named: Veozah, TZIELD, Heplisav-B, Evoke, PREVNAR 20, CAPLYTA, ZEPBOUND, CREON.
Industry payments across GA — which companies pay providers there.
